Cambridge, UK, 15 June 2006 – BioProgress plc (“BioProgress” or the “Company”) (AIM: BPRG; NASDAQ: BPRG), the speciality pharma and healthcare company, today announces the appointment of Peter Keen as the Group’s new Finance Director with effect from the 3rd July.
